This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reinecke, H. Articles by Laflamme, M. A. Search for Related Content PubMed PubMed Citation Articles by Reinecke, H. Articles by Laflamme, M. A. Pubmed/NCBI databases Medline Plus Health Information Heart Attack Stem Cells Related Collections Contractile function Other myocardial biology Congestive Animal models of human disease Myogenesis Other Treatment Acute myocardial infarction

(Circulation Research. 2008;103:1058.)
© 2008 American Heart Association, Inc.

Reviews

Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells

Hans Reinecke, Elina Minami, Wei-Zhong Zhu, Michael A. Laflamme

From the Center for Cardiovascular Biology (H.R., E.M., W.-Z.Z., M.A.L.), Institute for Stem Cell and Regenerative Medicine; and Departments of Pathology (H.R., W.-Z.Z., M.A.L.) and Medicine/Cardiology (E.M.), University of Washington, Seattle.

Correspondence to Michael A. Laflamme, MD, PhD, Department of Pathology, Center for Cardiovascular Biology, Institute for Stem Cell & Regenerative Medicine, University of Washington, 815 Mercer St, Seattle, WA 98109. E-mail laflamme{at}u.washington.edu

This Review is part of a thematic series on Cellular Therapy, which includes the following articles:

The Stem Cell Movement [2008;102:1155–1168] Aging and Disease as Modifiers of Efficacy of Cell Therapy [2008;102:1319–1330]

Genetic Enhancement of Stem Cell Engraftment, Survival, and Efficacy [2008;102:1471–1482]

Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells

Paracrine Signaling in Cell Transplantation

Assessment and Optimization of Cell Engraftment After Transplantation

Stem Cell Homing to Sites of Injury

Regulatory Considerations in Cell Transplantation
Eduardo Marbán Editor

In recent years, cell transplantation has drawn tremendous interest as a novel approach to preserving or even restoring contractile function to infarcted hearts. A typical human infarct involves the loss of approximately 1 billion cardiomyocytes, and, therefore, many investigators have sought to identify endogenous or exogenous stem cells with the capacity to differentiate into committed cardiomyocytes and repopulate lost myocardium. As a result of these efforts, dozens of stem cell types have been reported to have cardiac potential. These include pluripotent embryonic stem cells, as well various adult stem cells resident in compartments including bone marrow, peripheral tissues, and the heart itself. Some of these cardiogenic progenitors have been reported to contribute replacement muscle through endogenous reparative processes or via cell transplantation in preclinical cardiac injury models. However, considerable disagreement exists regarding the efficiency and even the reality of cardiac differentiation by many of these stem cell types, making these issues a continuing source of controversy in the field. In this review, we consider approaches to cell fate mapping and establishing the cardiac phenotype, as well as the present state of the evidence for the cardiogenic and regenerative potential of the major candidate stem cell types.

Key Words: stem cell • progenitor • myogenesis • cardiomyocyte • myocardial infarct

This article has been cited by other articles:

				H. C. Quevedo, K. E. Hatzistergos, B. N. Oskouei, G. S. Feigenbaum, J. E. Rodriguez, D. Valdes, P. M. Pattany, J. P. Zambrano, Q. Hu, I. McNiece, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity PNAS, August 18, 2009; 106(33): 14022 - 14027. [Abstract] [Full Text] [PDF]

				K. D. Boudoulas and A. K. Hatzopoulos Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease Dis. Model. Mech., July 1, 2009; 2(7-8): 344 - 358. [Abstract] [Full Text] [PDF]

				S. Takei, H. Ichikawa, K. Johkura, A. Mogi, H. No, S. Yoshie, D. Tomotsune, and K. Sasaki Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1793 - H1803. [Abstract] [Full Text] [PDF]

				S. Kaushal, C. P. Bouchard, and L. E. Wold Myocardial oxygenation is critical for improving regeneration capacity Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1215 - H1216. [Full Text] [PDF]

				F. Rochais, K. Mesbah, and R. G. Kelly Signaling Pathways Controlling Second Heart Field Development Circ. Res., April 24, 2009; 104(8): 933 - 942. [Abstract] [Full Text] [PDF]

				A. Abbate, G. G. L. Biondi-Zoccai, B. W. Van Tassell, and A. Baldi Cellular preservation therapy in acute myocardial infarction Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H563 - H565. [Full Text] [PDF]